Online inquiry

IVTScrip™ mRNA-Human WNT4, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK2278MR)

This product GTTS-WK2278MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the WNT4 protein. This product can be used in -related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_030761
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification oligo-dT affinity purification
Target Gene
Gene ID 54361
UniProt ID P56705
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human WNT4, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) (GTTS-WK2278MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK11228MR IVTScrip™ mRNA-Human ACKR4, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ACKR4
GTTS-WK7447MR IVTScrip™ mRNA-Human ADGRL3, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ADGRL3
GTTS-WK9173MR IVTScrip™ mRNA-Human ACTR3B, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ACTR3B
GTTS-WK17857MR IVTScrip™ mRNA-Human AMOTL2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AMOTL2
GTTS-WK28644MR IVTScrip™ mRNA-Human ARL5A, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARL5A
GTTS-WK9830MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA Additional GABA Compounds
GTTS-WK24782MR IVTScrip™ mRNA-Human ARRDC4, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARRDC4
GTTS-WK23269MR IVTScrip™ mRNA-Human ARPC4, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARPC4
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →